Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial.
Saved in:
| Title: | Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial. |
|---|---|
| Authors: | Kaul I; Karuna Therapeutics, Boston, Massachusetts., Sawchak S; Karuna Therapeutics, Boston, Massachusetts., Walling DP; CenExel, Garden Grove, California., Tamminga CA; Department of Psychiatry, University of Texas Southwestern Medical School, Dallas., Breier A; Department of Psychiatry, Indiana University School of Medicine, Indianapolis., Zhu H; Karuna Therapeutics, Boston, Massachusetts., Miller AC; Karuna Therapeutics, Boston, Massachusetts., Paul SM; Karuna Therapeutics, Boston, Massachusetts., Brannan SK; Karuna Therapeutics, Boston, Massachusetts. |
| Source: | JAMA psychiatry [JAMA Psychiatry] 2024 Aug 01; Vol. 81 (8), pp. 749-756. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print Cited Medium: Internet ISSN: 2168-6238 (Electronic) Linking ISSN: 2168622X NLM ISO Abbreviation: JAMA Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6238 |
|---|---|
| DOI: | 10.1001/jamapsychiatry.2024.0785 |
